BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mainetti LE, Rico MJ, Kaufman CD, Grillo MC, Guercetti J, Baglioni MV, Del Giúdice A, Capitani MC, Fusini M, Rozados VR, Scharovsky OG. Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models. Oncotarget 2020;11:3048-60. [PMID: 32850009 DOI: 10.18632/oncotarget.27694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chan WJ, Tseng FG. Nanomedicine in boron neutron capture therapy for cancer treatment: opportunities, challenges and future perspectives. Nanomedicine (Lond) 2021;16:1631-4. [PMID: 34264135 DOI: 10.2217/nnm-2021-0082] [Reference Citation Analysis]
2 Muñoz R, Girotti A, Hileeto D, Arias FJ. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment. Cancers (Basel) 2021;13:5414. [PMID: 34771577 DOI: 10.3390/cancers13215414] [Reference Citation Analysis]